These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39034917)

  • 1. Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial.
    Verhaar BJH; Wijdeveld M; Wortelboer K; Rampanelli E; Levels JHM; Collard D; Cammenga M; Nageswaran V; Haghikia A; Landmesser U; Li XS; DiDonato JA; Hazen SL; Garrelds IM; Danser AHJ; van den Born BH; Nieuwdorp M; Muller M
    Hypertension; 2024 Oct; 81(10):2124-2136. PubMed ID: 39034917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.
    Staessen JA; Thijs L; Stolarz-Skrzypek K; Bacchieri A; Barton J; Espositi ED; de Leeuw PW; Dłużniewski M; Glorioso N; Januszewicz A; Manunta P; Milyagin V; Nikitin Y; Souček M; Lanzani C; Citterio L; Timio M; Tykarski A; Ferrari P; Valentini G; Kawecka-Jaszcz K; Bianchi G
    Trials; 2011 Jan; 12():13. PubMed ID: 21235787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    MacIntyre IM; Turtle EJ; Farrah TE; Graham C; Dear JW; Webb DJ;
    Circulation; 2022 Feb; 145(6):416-423. PubMed ID: 35130054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension.
    Verweij P; Danaietash P; Flamion B; Ménard J; Bellet M
    Hypertension; 2020 Apr; 75(4):956-965. PubMed ID: 32063059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Zhang DY; Cheng YB; Guo QH; Shan XL; Wei FF; Lu F; Sheng CS; Huang QF; Yang CH; Li Y; Wang JG
    Circulation; 2020 Nov; 142(19):1821-1830. PubMed ID: 33019798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
    Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial.
    Tilves C; Yeh HC; Maruthur N; Juraschek SP; Miller E; White K; Appel LJ; Mueller NT
    J Am Heart Assoc; 2022 Jul; 11(13):e024763. PubMed ID: 35730613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Dong JY; Qin LQ; Zhang Z; Zhao Y; Wang J; Arigoni F; Zhang W
    Am Heart J; 2011 Dec; 162(6):959-65. PubMed ID: 22137067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ; Robinson TG; Potter JF
    Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
    Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
    Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
    Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
    Feig DI; Soletsky B; Johnson RJ
    JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension.
    Ferdinand KC; Izzo JL; Lee J; Meng L; George J; Salsali A; Seman L
    Circulation; 2019 Apr; 139(18):2098-2109. PubMed ID: 30786754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.